- Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Johnson, J.R., Cohen, M., Sridhara, R., Chen, Y.F., Williams, G.M., Duan, J., Gobburu, J., Booth, B., Benson, K., Leighton, J., Hsieh, L.S., Chidambaram, N., Zimmerman, P., Pazdur, R. Clin. Cancer Res. (2005)